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 INTRODUCTION
Abdominal  straining  is  assumed  to  be  a  symptom  of  bladder  outlet 
obstruction( BOO). It is included in the various symptom scores which are 
used  for  the  assessment  of  patients  presenting  with  lower  urinary  tract 
symptoms  (LUTS)  suggestive  of  BOO.1-4 It  is  presumed  that  straining 
augments  urinary  flow.  However  there  is  a  sparse  literature  linking 
abdominal  straining  and  outlet  obstruction.  Furthermore  there  is  little 
evidence that straining is specifically a feature of BOO and the effect it has 
on the flow of young asymptomatic men or symptomatic men. It has been 
shown that upto 25% of men strain habitually though no large longitudinal 
population  based  studies  have  been  done5.  Uroflowmetry  and  postvoid 
residual urine volume (PVR) are useful screening tests in the evaluation of 
men with LUTS but neither can make a definitive diagnosis of BOO. Most 
men with  BOO have diminished flow rates,  6 and 90% of neurologically 
normal men with a maximum flow rate (Qmax) of 
less than 10 mL/sec are obstructed.7  conversely, 25% to 30% of men with 
decreased  flow  are  not  obstructed.  Decreased  uroflow  can  result  from 
impaired  detrusor  contractility  or  obstruction.  Without  the  synchronous 
measurement  of detrusor  pressure  (Pdet),  uroflow is  unable  to  distinguish 
between these 2 entities.8-10.  Similarly,  a normal uroflow does not exclude 
outlet obstruction. Urodynamics with pressure flow studies remain the gold 
standard for diagnosing BOO and other voiding and storage abnormalities 
responsible for LUTS and voiding dysfunction. We wished to determine if 
there  is  any  correlation  between  the  symptoms  of  straining  to  objective 
urodynamic parameters.
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                         AIM OF THE STUDY
To  evaluate  the  relationship  between  bladder  outlet  obstruction  and 
abdominal straining in men > 45 yrs of age.
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Review of Literature
Pathophysiology of BOO: The partially obstructed urethra, detrusor muscle 
and the central nervous system function interact to produce lower urinary tact 
symptoms (LUTS). These were historically referred to as ‘prostatism’ . There 
are several mechanisms by which Benign prostatic hyperplasia (BPH) may 
cause obstruction such as a prominent median lobe acting as a ball valve, a 
dynamic obstruction related to the contractile properties of prostatic smooth 
muscle, a static obstruction resulting from an enlarged prostate enveloping 
the   prostatic  urethra,  or  a  restricted  surgical  capsule.  Each  of  these 
mechanisms is clinically feasible and components of each are likely to be 
present in most instances. The result is a raised intravesical pressure and a 
reduction  in  flow  which  leads  to  the  gradual  development  of  secondary 
changes in the muscle itself.
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Effect  of  obstruction  on  the  bladder:  Gross  anatomical,  histological, 
cellular  and  molecular  alterations  in  bladder  wall,  which  result  from 
obstruction of the urethra impair its function and add to the symptomatology 
of  BPH11.  Hypertrophy of  the  detrusor  muscle  in  early  phases of  outflow 
obstruction allows a compensatory increase in detrusor pressure in order to 
maintain flow in the presence of increased outflow resistance. With persistent 
obstruction however decreased compliance in the bladder wall and impaired 
emptying  occur  owing  to  the  deposition  of  increasing  amounts  of 
extracellular matrix (ECM)12. Acute urinary retention may occur during the 
process and may be related to bladder failure, as well as to sudden increase in 
outflow  obstruction.  The  alteration  in  ECM is  probably  the  predominant 
pathophysiological feature in long term obstruction. Studies from the rabbit 
model of obstruction have shown that significant smooth muscle hyperplasia 
is induced when the load is increased and that this is associated with down 
regulation of myosin light chain (MLC) Expression. This effect contributes to 
the  decreased  smooth  muscle  contractility  and  moreover  results  in 
development of dedifferentiated smooth muscle phenotype13
Figure 1:The pathophysiology of BOO*(Adapted from Wein: Campbell-Walsh Urology, 8th ed. 
Physiology and Pharmacology of the Bladder and Urethra, p1303)
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Natural History of Benign Prostatic Enlargement: 
The natural  history  of a  disease refers  to the  progression of the  untreated 
disease  over  time.  Clinical  endpoints  of  progression  for  BPH include  the 
development of more severe symptoms, bladder dysfunction manifested by 
incomplete  emptying  or  detrusor  instability,  more  severe  bladder  outlet 
obstruction, acute urinary retention (AUR), recurrent UTI, urosepsis, chronic 
renal insufficiency, bladder stones, incontinence, and hematuria. The natural 
history  of  BPH  is  incompletely  understood  because  of  the  absence  of  a 
uniform definition of the disease and the lack of rigorous studies. Insights 
into the natural history of benign prostatic enlargement can be gleaned from 
the  longitudinal  follow-up  of  the  Olmstead  County  Study  of  Urinary 
Symptoms and Health Status.14A relatively small subset of men between the 
ages  of  40  and  79  were  randomly  selected  from  the  Olmstead  County 
community and underwent transrectal ultrasonography at baseline 
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and 6 years  later.  A mixed-effects  regression model  showed that  prostate 
volume increased by about 1.6% per year on average.
Men with larger  prostates  at  baseline experienced the greatest  increase in 
prostatic volume. Jacobsen and colleagues27 reported
on LUTS progression in the Olmstead County Study over an interval of 42 
months.  The  AUA  symptom score  was  categorized  as  mild  (0-7)  versus 
moderate  to  severe  (8-35).  There  was  much  movement  across  symptom 
categories during the follow-up interval.  At 42 months,  22% of men with 
mild symptoms crossed over to moderate to severe symptoms. A regression 
model showed that the average symptom score change over time was 0.18 
symptom units  per  year.  The  AUA symptom score  increased  during  this 
interval  of  time  in  all  age  categories.  The  greatest  mean  symptom score 
progression was observed in the 60- to 69-yearold
age  group.  The  Medical  Therapy  of  Prostatic  Symptoms (MTOPS)  study 
represents the longest placebo-controlled trial to date of men 
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with BPH.15 It is important to note that prostate volume was not an inclusion 
criterion for enrollment. Thus, the placebo arm provides
insights into the natural history of men with moderate to severe LUTS and 
decreased peak urinary flow rates, which imply some level of bladder outlet 
obstruction. The objective of the MTOPS study was to examine the impact of 
medical therapies on BPH progression. In this study, BPH progression was 
defined as a 4-point increase in AUA symptom score or the development of 
AUR, chronic renal insufficiency or socially unacceptable incontinence, or 
recurrent  UTI  or  urosepsis.  The  final  analysis  of  the  MTOPS study  was 
recently conducted with a mean follow up of 4.5 years. The only clinically 
relevant progression rates were
observed for symptom progression and AUR. The overall progression rate 
(events/100 patient-years) was 4.5 in the placebo group. The MTOPS study 
demonstrated that the development of AUR is quite common in men with 
clinical BPH. This is consistent 
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with the Olmstead County Study of Urinary Symptoms. and Health Status, 
which reported a cumulative incidence rate for AUR of
6.8 Per thousand person-years. With a multivariate analysis, age at baseline, 
symptom severity, and peak flow rate independently predicted risk of AUR. 
Prostate  volume was not  evaluable  as  a  predictive  factor  as  only  a  small 
subset of men underwent prostate volume determination at baseline. Based 
on information from the Olmstead County Study, a  60-year-old man with 
moderate to severe symptoms has a 13.7% chance of developing AUR by age 
70.  The  placebo  arms  of  long-term  studies  evaluating  the  safety  and 
effectiveness of the 5ARIs dutasteride  16,17  and finasteride18 provide insights 
into the risk of AUR in men with LUTS, bladder outlet obstruction, and an 
enlarged prostate. In men with prostates over 58 cm3, the risk of AUR in the 
finasteride study placebo group over the 4-year period was 22%.
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LUTS  and  BPH:  Benign  prostatic  hyperplasia  (BPH)  is  a  progressive 
disease that is commonly associated with bothersome
lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, 
nocturia,  decreased  and  intermittent  force  of  stream and  the  sensation  of 
incomplete  bladder  emptying.  The  term  ‘BPH’  actually  refers  to  a 
histological condition, namely the presence of stromal-glandular hyperplasia 
within the prostate gland19. The condition becomes clinically relevant if and 
when  it  is  associated  with  bothersome  LUTS;  however,  the  relationship 
between BPH and LUTS is complex, because not all men with histological 
BPH  will  develop  significant  LUTS,  while  other  men  who  do  not  have 
histological BPH will develop LUTS. Benign prostatic enlargement (BPE) is 
another  component  of  the  LUTS  ⁄BPH  constellation  20.  Reflecting  the 
complex relationship between age related changes in the prostate, not all men 
with histological BPH will develop BPE; in addition, not all men with LUTS 
will have concomitant BPE, and not all men with BPE will have bothersome 
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LUTS. The final component of this complex relationship is bladder outlet 
obstruction (BOO). This results from a pressure gradient at the bladder neck ⁄ 
prostatic urethra and may lead to compression of the urethra, compromised 
urinary flow and deterioration of the upper urinary tract with renal failure. 
Yet again, not all men with BPH⁄ BPE and LUTS will have BOO, and there 
are causes of BOO other than BPH⁄ BPE (e.g. primary bladder neck sclerosis 
or a
urethral stricture). The causes of LUTS are multifactorial, although
BPE secondary  to  BPH is  a  major  contributing factor.  The prevalence of 
LUTS in Europe varies with age, ranging from 14% for men in their fourth 
decade of life to > 40% for men in their sixth decade21. Although bothersome 
LUTS are commonly the
only  determinant  for  a  BPH  diagnosis  in  clinical  practice,  simple 
investigations  exist  that  can  be  highly  effective  in  accurately  diagnosing 
LUTS  because  of  BPH.  The  European  Association  of  Urology  (EAU) 
guidelines  recommend a  series  of  initial  evaluations  for  men  with  LUTS 
suggestive of bladder obstruction; 
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these  include  taking  a  clinical  history,  using  a  validated  questionnaire  to 
assess  symptoms,  conducting  a  physical  examination,  creatinine 
measurement,  urinalysis,  flow rates,  postvoid  residual  (PVR)  volume and 
serum  prostate-specific  antigen  (PSA)  measurement  (particularly  when  a 
diagnosis of
prostatic carcinoma would affect the decision about which therapeutic option 
to use)22. The initial evaluations recommended by the American Urological 
Association (AUA) are a clinical history, use of a validated questionnaire to 
assess  symptoms,  a  physical  examination,  urinalysis  and  serum  PSA 
measurement 23
It has been demonstrated that there is a high correlation between diagnoses 
using  medical  history,  serum PSA,  digital  rectal  examination  (DRE)  and 
International  Prostate  Symptom  Score  (IPSS)  and  those  based  on  a  full 
battery of tests including ultrasonography , uroflowmetry and urodynamics24.
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Urodynamics in Diagnosis: Urodynamic studies are the most
definitive tests available to determine the etiology of voiding dysfunction and 
lower urinary tract symptoms. The urodynamic study can be divided into 2 
parts, the filling and storage phase (cystometrogram) and the voiding phase 
(voiding pressure flow
study).  The voiding phase allows one to definitively  make a diagnosis of 
obstruction, as detrusor pressure and urinary flow rate can be measured and 
outlet resistance calculated. However the filling and storage phase measured 
by the cystometrogram (CMG) can provide useful information in the patient 
in  whom  obstruction  is  suspected,  for  example,  detrusor  overactivity,  or 
involuntary contractions, may be present (with or without obstruction) and 
may account for symptoms. Sensation and capacity also can be determined. 
Another  urodynamic  parameter  is  impaired  compliance.  Normally  the 
bladder should hold increasing volumes of urine at low pressures indicating a 
highly  compliant  structure  (compliance  =change  in  volume/change  in 
pressure). Impaired 
                                                    16
compliance may result from several conditions including neurogenic voiding 
dysfunction, radiation cystitis, tuberculosis,
and chronic bladder outlet obstruction. In the case of obstruction,
compliance appears to deteriorate as a result of high intravesical
pressure generated by bladder muscular activity opposed by inappropriately 
high  outlet  resistance.  Prolonged  high-storage  pressures  are  known to  be 
detrimental  to renal  function.25 The simultaneous measurement of detrusor 
pressure and urinary flow
rate during voluntary voiding is one of the best ways currently available to 
access  2  critical  parameters  of  bladder  and  outlet  function:  detrusor 
contractility  (normal  vs.  impaired)  and  outlet  resistance  (obstructed  vs. 
unobstructed). In general, pressure-flow
studies identify 3 fundamental voiding states:
1) Low detrusor pressure and high flow rate (unobstructed)
2) High detrusor pressure and low flow rate (obstructed)
3) Low detrusor pressure with low flow rate (poor detrusor
contractility).
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It is important to understand that pressure-flow studies do not always allow 
for an absolute classification into one distinct category. Borderline cases exist 
as well as cases in which there is a combination of impaired contractility and 
obstruction. 
Measures  of  Outlet  Resistance  and  Obstruction:  Attempts  to 
mathematically define urethral resistance date back to the early 1960s.26 Early 
equations calculating urethral resistance, such as
R = Pves/Q (where R = resistance, Pves = vesical pressure, and Q = flow 
rate), followed standard hydrodynamic formulae calculating outlet resistance. 
Unfortunately, these concepts failed to consider that the urethra has an active 
and distensible nature and is not a rigid tube. They also failed to consider the 
importance of bladder volume. Rigid tube hydrodynamics were abandoned in 
favor  of  more  dynamic  ways  to  analyze  micturition.  In  1972,  Griffiths 
introduced Bladder Output Relation (BOR), which depicted the interrelation 
between bladder pressure and uroflow at a given volume.27,28 According to 
the BOR, for any given bladder there is
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A specific bladder output relation and the higher the bladder pressure, the 
lower the flow and vice versa. The BOR essentially measures the function of 
the  bladder  independent  of  the  function  of  the  urethra.  Griffiths  further 
defined  a  method  to  evaluate  urethral  resistance  independent  of  bladder 
function: the urethral resistance relation (URR).29According to this relation, 
as bladder pressure rises; the flow rate will be zero until the intrinsic bladder 
pressure
equals the intrinsic urethral pressure. At this point flow will start
and  the  flow  rate  will  rise  rapidly  with  further  increases  in  the  intrinsic 
bladder  pressure.  If  pairs  of  simultaneously  measured  values  of  detrusor 
pressure and flow rate are plotted against one another throughout the course 
of a micturition event, a curve is obtained that shows the resistance to flow 
independent of detrusor function, representing the urethral resistance relation. 
A change in one of these relations during micturition would not affect the 
curve  representing  the  other  relation  but  would  result  in  the  point  of 
intersection to move along that curve. In 1979, Abrams and 
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Griffiths  defined  a  simple  nomogram for  the  diagnosis  of  obstruction  in 
males.30 The researchers collected pressure flow data on 117 males older than 
age  55  years,  who  were  evaluated  for  possible  prostatic  obstruction.  By 
comparing pressure-flow data
between these patients and plotting the Qmax on the X axis and the
detrusor pressure (Pdet) at maximum flow (Pdet @ Qmax) rate on the Y axis, 
they  created  3  zones  representing  obstructed,  unobstructed,  and equivocal 
micturition. The zone boundaries were created by a combination of empiric 
observations and theoretical
considerations.  Conceptually,  the  Abrams-Griffiths  nomogram  does  not 
permit  a  diagnosis  of  impaired  detrusor  contractility  with  or  without 
coexisting BOO. The passive urethral resistance relation
(PURR) developed by Schafer 31,32 in 1983 constitutes a simplified
model  of  Griffith’s  URR.  The  PURR  curve  describes  the  relationship 
between pressure and flow during the period of lowest  urethral  resistance 
(i.e.,  during complete relaxation), and therefore defines the lowest urethral 
resistance during a single voiding event. 
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The importance of a minimum opening pressure in describing a collapsible 
tube is considered. Outlet function is characterized by 2 simple parameters: 
the minimum opening pressure, reflecting
collapsibility  of  the  tube,  and  the  cross-sectional  area  of  the  flow-rate 
controlling zone, reflecting extensibility.33 Therefore, the PURR curve is a 
method of assessing the presence or absence of BOO independent of inherent 
detrusor  strength.  The  PURR  was  the  first  attempt  to  quantify  relevant 
features of the voiding cycle describing the interplay of detrusor capability 
and bladder outlet resistance. Schafer subsequently modified the PURR by 
using a straight line instead of a parabolic curve.34 Schafer divided this linear 
PURR  (LinPURR)  curve  into  7  zones  labeled  0  to  VI  corresponding  to 
increasing grades of obstruction: grades 0 and 1, no obstruction; grade 2, 
equivocal  or  mild  obstruction;  grades  3  to  6,  increasing  severity  of 
obstruction.  The  boundary  between  grades  2  and  3  corresponds  to  the 
boundary  between  equivocal  and  obstructed  in  the  Abrams-Griffiths 
nomogram. The linear PURR 
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also  allowed  for  the  assessment  of  detrusor  contractility  independent  of 
obstruction (strong, normal, weak, and very weak).
Finally  in  1989,  Griffiths  and  associates  developed  a  single  urethral 
resistance parameter, URA.35 Using data from a mixed group of patients, they 
determined that obstruction is represented by URA values greater than 29 cm 
H2O. In the past 10 years, work has been done to simplify the diagnosis of 
BOO in men and to create a standardized method for diagnosis, based on the 
work  of  different  authors  described  above.   In  1997,  the  International 
Continence Society (ICS) introduced the provisional ICS nomogram, which 
is recommended for the diagnosis of obstruction in older men with LUTS 
suggestive of benign prostatic
obstruction  (BPO).36 This  was  based  on  extensive  studies  and  concepts 
developed by Griffith, Abrams and Schafer. Lim and Abrams showed that 
patients  were  identically  classified  by  the  Abrams-Griffiths  and  Schafer 
nomograms and there  was  only  a  6% discrepancy  between these  and the 
URA nomogram described by 
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Griffiths.38 They also described the Abrams-Griffiths number derived from 
the slope of the dividing obstructed and equivocal
groups on the Abrams-Griffiths nomogram and the same line dividing the 
obstructed (II) and slightly obstructed (III) on the Schafer nomogram. The 
Abrams-Griffiths number was later renamed the bladder outlet obstruction 
index (BOOI) and is represented by the equation: BOOI = Pdet @ Qmax – 2 
Qmax.
Figure  2:  The  ICS  Nomogram.  The  patients  are  divided  into  3  classes: 
unobstructed,  obstructed  and  equivovocal  based  on  the  bladder  outlet 
obstruction index (BOOI). From Abrams 35 ICS 
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International  continence  society;  Pdet  detrusor  pressure;  Qmax  maximum 
flow rate.
                                                                
Figure 3: Bladder contractility nomogram. The patients are divided 3 classes; 
strong, normal and weak contractility based on Bladder Contractility Index 
(BCI). From Abrams 35 Pdet: detrusor pressure; Qmax Maximum flow rate
Using this ICS nomogram, men can be divided into obstructed, equivocal, 
and unobstructed according to their BOOI: 
BOOI > 40 = obstructed;
BOOI 20-40 = equivocal; and
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BOOI< 20 = unobstructed (Figure 2). 
For purposes of standardization, this nomogram is recommended for use in 
older men with LUTS suggestive of BPO.
Significance of straining: Jensen et al36 studied the frequency of abdominal 
straining during cystometry and pressure flow studies in men more than 50 
yrs who presented with LUTS. Approximately 25-35% of men in this study 
either  strained  before  the  start  of  detrusor  contraction,  during  the  rise  in 
detrusor pressure or during flow. Reynards et al37 studied the prevalence of 
abdominal straining during free flow in patients with symptomatic BPH and 
it showed that approximately 25% of men strained during voiding. Garraway 
et al38 in a study of the prevalence of symptoms of prostatic dysfunction in 
men aged 40-79 years in Scotland , found that only 0.4% of men said they 
strained to void and 11% said they occasionally strained to void. A survey of 
urinary symptoms in an unselected community based group of men in united 
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states39reported straining in 15% of men aged over 50 years. Two thirds of 
these  subjects  reported  this  symptom to  be  bothersome.  In  the  study  by 
Reynolds et al straining some or most of the time was reported by 13% of 
men and straining occasionally by 44%. A higher prevalence of symptoms is 
to  be  expected  in  men  who  specifically  present  with  voiding  problems. 
Straining  to  void  is  an  even more  common symptom in  men undergoing 
TURP, prevalence rates of 30-40% being reported in two studies from United 
States.40,  41 There are few reports relating the symptom of straining to void 
with objective evidence of straining during voiding. Jensen et al noted that 
half  of the patients who claimed not to strain during voiding did actually 
show objective evidence of straining during micturition. Only a few studies 
have explored the relationship between abdominal straining and BOO. Susset 
et  al  commented  that  during  voiding  patients  with  obstruction  usually 
required added pressure provided by straining. However the number in this 
study was small and no formal statistical 
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comparison  of  the  prevalence  of  straining  in  the  obstructed  and  the  non 
obstructed groups. Further more the symptoms of straining were still present 
in  11  of  15  men  following  TURP  in  study  by  Jensen  et  al.  Relief  of 
obstruction therefore does not seem to remove the need to strain. Mefflan et 
al 42 and Christmas et al43 studied the effect of abdominal straining on urinary 
flow rates in young men. In the former study, three men aged between 30 and 
40 years performed multiple flow tests with and without abdominal straining. 
Straining caused a marked increase in flow rate. In a group of normal young 
men and women Christmas et al  found that abdominal straining increased 
flow raters in men but not in women. Claridge et al44 studied the effect of 
straining to void during free flows in a group of men with prostatic or bladder 
neck obstruction defined on basis of high voididng detrusor pressure and on 
cystoscopic findings. He found that in 29 of 31 patients abdominal straining 
had  no  effect  on  the  flow rate.  Infact  in  10  men  the  flow rate  fell  with 
straining. He concluded that the fall in   
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flow  rate  indicated  a  rise  in  outflow  resistance,  probably  as  a  result  of 
external pressure on the intra abdominal part of the urethra. The flow rates 
remained  unchanged  or  fell  in  most  of  the  patients  who  Reynolds  et  al 
studied. 
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  Patients & Methods:
Research Questions:
1. Is there an association between BOO and abdominal straining?
2.  What is the incidence of straining during voiding in normal men?
3. Is there an Objective co-relation between the symptom of straining and 
abdominal pressure?
Inclusion Criteria for Cases:
Men more than 45 years of age with urodynamic proven obstruction as 
defined by the ICS criteria.
Inclusion criteria for controls: Normal Men more than 45 years who had 
no lower urinary tract symptoms
Exclusion Criteria for Cases:
1. Presence of Co morbidities like diabetes, hypertension, Ischaemic heart 
disease
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2. Previous surgery of urethra, prostate or bladder.
3.  Previous  pelvic  procedures  likely  to  cause  bladder  denervation  like 
Hysterectomy and Abdominoperineal excision of rectum.
4. Neurological diseases likely to influence the lower urinary tract         5. 
Overactive bladder 
6. Bladder calculus.
7.   Medications  like  anticholinergics,  diuretics,  antidepressants  and 
antipsychotics.
8.  Urinary tract infection
Calculation  of  Sample  size:  The  sample  size  was  calculated  from  a 
retrospective study comparing abdominal straining in those with BOO to 
those without
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Methodology:  The study was conducted in urology outpatient  clinic of 
Christian  medical  college,  Vellore.  This  was  prospective  case  control 
study. 
CASES: Men of age more than 45 years with LUTS attending the urology 
outpatient clinic were recruited for the study. They were asked to answer 
an international prostatic symptom score (IPSS) questionnaire (annexure 
1). All the demographic and clinical data were recorded in the proforma 
(annexure  2).  Evaluation  of  patients  began  with  detailed  history  and 
examination done by the investigator. Estimation of serum creatinine, and 
urine microscopy was done for all. Urine culture and sensitivity was done 
for those who were subjected to urodynamics. Those who have positive 
culture  with  LUTS  were  excluded  from the  study.  All  subjects  did  a 
representative uroflowmetry. Post void residual urine was measured using 
abdominal ultrasound using prolate ellipsoid formula; Volume (V) in ml = 
Length x Height x transverse diameter x π/6 or 0.53.
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Those with urinary free flow rate less than 10ml/sec underwent another 
free flow with abdominal pressure monitoring and urodynamic evaluation 
after written informed consent. The pressure-flow studies were done using 
medical measurement systems (MMS) UD 2000 equipment. Single dose 
of prophylactic antibiotic was given. Pretest residue was measured prior to 
urodynamic evaluation by placing two 6Fr infant feeding tubes. One of 
these  tubes  was  used  for  filling  as  well  as  for  intravesical  pressure 
measurement.   During cystometry  in  sitting posture,  bladder  was filled 
with  physiological  saline  at  37ºC  at  a  filling  rate  of  50ml/min.  First 
sensation  of  bladder  filling  (ml),  maximum  cystometric  capacity  (ml), 
detrusor  overactivity  (presence  or  absence),  incontinence  (presence  or 
absence),  and compliance (cmH2O) were assessed during filling phase. 
Maximum urinary flow (Qmax, ml/sec), Maximum intravesical pressure 
on  voiding  (cmH2O),  Voided  volume  (ml),  events  like  abdominal 
straining were noted during voiding 
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phase.  Abdominal  pressure  was  recorded  by  using  perforated  rectal 
balloon catheter.  Detrusor  pressure  was calculated by subtracting intra-
abdominal  pressure  from  intravesical  pressure.   Detrusor  pressure  at 
maximum urinary flow rate (Pdet at Qmax, cm H2O) was measured to 
evaluate  detrusor  contractility.  Methods,  definitions  and  units  were 
appropriate to the standards recommended by the international continence 
society.
Controls:
Men more than 45 years without any LUTS were recruited as controls 
after  written  informed  consent.  All  did  a  representative  uroflowmetry. 
Those  who had  flow rates  more  than  25  ml/sec  were  included.  These 
underwent  another  uroflowmetry  with  simultaneous  measurement  of 
abdominal  pressure.  This  was  measured  using  urodynamic  perforated 
rectal balloon catheter .
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Definitions:
1) Urinary incontinence was defined if the complaint of any involuntary 
leakage of urine was present in which stress urinary incontinence (the 
complaint of involuntary leakage on effort on exertion, or on sneezing or 
coughing),  or  urge  urinary  incontinence  (the  complaint  of  involuntary 
leakage  accompanied  by  or  immediately  preceded  by  urgency)  were 
noted.
2) Normosensitive bladder - Volume at first sensation of 150 -200ml
3) Delayed first  sensation  –  Appreciation  of  first  sensation  of  filling  at 
volume ≥250ml or greater than 50% of maximal cystometric capacity. 
4) Detrusor overactivity – Involuntary phasic increase in detrusor pressure 
that was difficult to control or could not be controlled by patient resulting 
in incontinence or voiding. 
5) Normal compliance –  Filling detrusor  pressure  of  5-20cmH2O in the 
absence  of  simultaneous  detrusor  contraction  at  maximum cystometric 
capacity.   
6) Normal maximum cystometric  capacity  –  Volume 350 to  600ml,  at 
which there was bladder contraction that resulted in voiding or patient 
discomfort.
7) Normal urinary flow rate – Catheterized urine flow rate of more than 
12ml/sec. 
8) Normal Pdet at Qmax -  > 10cm H2O or <40cmH2O during voiding 
with catheterized flow rate if more than 12ml/sec.
9) Normal post void residue – 50ml 
10) Hypocontractile detrusor  – Pdet at Qmax less than 10cmH2O or flat 
trace during voiding with or without abdominal straining. 
11) Bladder outflow obstruction – Pdet at Qmax more than 40cmH2O with 
catheterized urine flow rate less than 12ml/sec. Abrams Griffith Number 
calculated as Pdet-2Qmax  more than 40 
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Analysis
There were three groups for analysis
Group 1: Those with poor flow and proven BOO
Group 2: Those with poor flow but no obstruction 
Group 3: Normal men without LUTS
All statistical analyses were performed using Statistical Package for the 
social Sciences (SPSS 11.0) for windows. Categorical data was presented 
using frequencies and percentage.  Continuous data was described using 
mean ± standard deviation or  median and range.  Associations  between 
categorical  variables  were  assessed  using  chi-square  test  with  yates’ 
correction  or  fisher’s  exact  test.  Continuous  variables  were  compared 
using student‘t’ tests and Mann-Whitney tests were used for non-normal 
data. A p-value less than 0.05 was considered statistically significant. 
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                         Results
Patients included in final analysis: Total of 100 males were included in 
the study . Of these 60 were those who presented with LUTS and 40 who 
were asymptomatic. These were subdivided for analysis into three groups 
as above. The mean age of cases was 58 years and that of the controls was 
53 years. Neither had any co morbidities.
Prevalence of Straining:  Of those who presented with LUTS and had 
BOO on urodynamics (Group 1) approximately 40% strained on 
urodynamic studies as per the criteria defined for straining. In those who 
had LUTS but were not obstructed on urodynamics(group B) 58% 
strained. 30% of asymptomatic men also strained on free flow done with 
abdominal pressure monitoring by a rectal balloon. Comparison between 
these three groups was not statistically significant (p=0.12.) 
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Figure  4:  Comparison  of  objective  evidence  of  straining  on 
urodynamic/ free flow with abdominal pressure monitoring between 
the three groups
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Straining  as  a  symptom:  50%  of  those  who  presented  with  LUTS 
complained of straining to void. There was no statistical difference between 
the symptom of straining in those who had BOO and those who didn’t. (P 
value 0.12). 52% of those who had no symptom of straining on the IPSS but 
had  other  LUTS  had  obstruction  on  urodynamics.  Straining  symptom 
therefore was a poor indicator of BOO.
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Figure 5: Comparison of the symptom of straining between those who had 
BOO to those who were not obstructed on urodynamics
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Straining in Asymptomatic Men: 30% of asymptomatic men strained during 
free flow. Most of them commented that it was habitual and representative of their 
normal voiding pattern.
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Objective Evidence of Straining on Free Flow in Asymptomatic Men
Asymptomatic Men
Figure  6:  Straining  in  controls  on  free  flow  with  rectal  pressure 
monitoring.
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Effect  of  Straining  on  the  free  flow  rates:  To  ascertain  the  effect  of 
straining on free flow rates a comparative analysis was done between those 
who strained  and  those  who didn’t  in  each of  the  groups.  There  was  no 
statistically significant difference in mean, median, minimum or maximum 
flow rates in either group. Among cases the mean flow rate was 6 ml/sec and 
6.2 ml/sec in those who strained and those who didn’t respectively. 
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Figure: Comparison of flow rates in those with LUTS
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Comparison  among  asymptomatic  men  did  not  reveal  any  statistical 
difference in the mean, minimum or maximum flow rates among those who 
strained and those who didn’t. (p value 0.311). An example of straining on 
free flow is shown in figure 7.
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Figure 6: Comparison of flow rates in asymptomatic men 
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 Figure  7:  straining  pattern  on  free  flow  with  abdominal  pressure 
monitoring in an asymptomatic male.                
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             IPSS Scores: The mean IPPS score among the cases was 18. Apart from the 
symptom of straining other symptoms were analyzed in the cases. Among 
those  who  had  BOO  none  of  the  storage  or  other  voiding  LUTS  were 
statistically significant for BOO. Among those who had LUTS but no BOO 
on urodynamics none of the other symptoms had any statistically significant 
correlation (p value 0.16).
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Discussion
The term ‘‘lower urinary tract symptoms’’ (LUTS) is an umbrella term 
that was introduced originally in 1994 to dissociate urinary symptoms in 
the male patients from any implied specific site of origin of symptoms, 
such as the prostate19. It is now recognized that LUTS is a global term that 
encompasses  all  urinary  symptoms,  including  storage,  voiding,  and 
postmicturition  symptoms.  This  terminology  links  well  with  the 
classification  proposed  by  Wein20,  which  suggested  that  disorders  of 
micturition would be more elegantly characterized
as ‘‘failure to store’’ or ‘‘failure to empty.’’ In this context, it is important 
to  acknowledge the fact  that  it  has  been known that  symptoms do not 
relate  to  the  underlying  pathophysiology  in  many  patients;  indeed  the 
phrase ‘‘the bladder is an unreliable witness’’ was coined to acknowledge 
this45.Historically, voiding symptoms have been related to obstruction of 
the bladder outlet. The traditional association in men is with the prostate, 
the so-called symptoms of ‘‘prostatism.’’ However, it is well recognized 
that  voiding  symptoms  poorly  correlate  with  underlying 
pathophysiology46. Similar symptoms can also be produced by any other 
form of obstruction, such as a urethral stricture or, conversely, by poor 
function  of  the  lower  urinary  tract  in  circumstances  in  which  there  is 
impaired  detrusor  contractility.  This  has  led  to  the  recognition  that, 
although LUTS may commonly be related to bladder outlet obstruction 
(BOO) as a result of benign prostatic obstruction (BPO), which is often 
associated  with  benign  prostatic  enlargement  resulting  from  the 
histological condition of benign prostatic hyperplasia (BPH), this is not 
invariably  the case.  Failure  to empty  can be related either  to  an outlet 
obstruction or to detrusor underactivity of the bladder, or to a combination 
of both. Postmicturition symptoms, such as post void dribbling, occur in 
both sexes, but most often in men, in whom these symptoms are highly 
common, very troublesome, and cause significant interference with quality 
of life. Storage symptoms are currently largely encompassed by the term 
overactive  bladder  (OAB)  syndrome,  which  is  defined  as  urgency, 
frequency, nocturia, and urgency incontinence 47, and which is believed to 
be correlated with underlying detrusor overactivity. These symptoms tend 
to  be  more  bothersome  than  voiding  symptoms,  especially  if  they  are 
associated with incontinence48.The most recent international  population-
based survey, the EPIC study49, was conducted in five countries using the 
2002  ICS  definitions  for  LUTS38.  This  survey  assessed  prevalence  of 
OAB,  urinary  incontinence,  and  LUTS in  more  than  19  000  men and 
women.  The  data  showed  that  there  is  a  higher  prevalence  of  storage 
(51.3%)  versus  voiding  symptoms  (25.7%)  in  men  and  all  LUTS, 
including OAB, in addition to histologic BPH increase in prevalence as 
men age.  The EPIC study  demonstrated  that  the  majority  of  men with 
voiding  symptoms did  not  experience  these  in  isolation  but  had  either 
storage and/or postmicturition
symptoms as well. Specifically, among men with LUTS, 9% experienced 
both  storage  and  voiding  symptoms,  whereas  an  additional  9% 
experienced storage, voiding, and postmicturition symptoms. It  has also 
been shown that there is a far better correlation between storage LUTS and 
urodynamics than with Voiding LUTS. In our study however there was no 
statistically significant correlation between any of the 4 storage or the 3 
voiding LUTS in the IPPS with the urodynamic findings. The EpiLUTS 
study,  a  cross-sectional,  population  representative  Internet  survey 
conducted in the United States, the United Kingdom, and Sweden to assess 
prevalence of LUTS, also found that both males and females who reported 
having voiding
symptoms were more likely to experience either storage or postmicturition 
symptoms, or both50. Data from the US study showed that 10.7% of the 
male  population  40  yr  and  older  had  voiding  symptoms,  10.1% 
experienced both voiding and storage symptoms, and 24.2% experienced 
voiding, storage, and postmicturition symptoms. In our study also most of 
the  men  who complained  of  voiding  LUTS also  had  storage  and  post 
micturition symptoms. 
Uroflowmetry remains a useful screening test in the evaluation of LUTS. 
It  assesses the combination of detrusor force and outflow opening and, 
thus, gives an indirect indication of these aspects of bladder function. Flow 
rates  must  be  interpreted  together  with  the  voided  volume  sine  low 
volumes may give inaccurate flow-rate measurements. The most important 
parameter  in  men  with  LUTS  is  the  maximum  flow  rate  (Qmax); 
additional information is gained by looking at the voiding time and the 
flow  pattern.  It  is  mandatory  to  have  more  than  one  flow-rate 
measurement,  as  they  can  be  variable  (depending  on  voided  volume, 
diurnal variation). The voided volume should be>150ml. For patients with 
decreased flow rates who are suspected of BPO, urodynamic studies have 
shown that BOO was present in 88% of those with a Qmax <10 ml/s, in 
57% of those with a Qmax of 10–14 ml/s, and in only 33% of those with a 
Qmax >15 ml/s 51. Thus, a decreased flow rate implies a high likelihood of 
BOO due to BPO. Following this study by Abrams et al, a Qmax cut-off 
of  15  ml/s  has  been  widely  accepted  as  signifying  BPO  requiring 
treatment.  To  further  increase  the  probability  of  detecting  BOO  we 
included those with flow rates of less than 10ml/sec as cases. Also a flow 
rate before the urodynamics was done to reduce the effect of intravesical 
lines  on  the  maximum  flow.  Straining  during  voiding  is  one  of  the 
questions in the IPSS. There has been sparse literature on the correlation 
between the symptom and the objective documentation on urodynamics. 
In the previous studies by Jensen et al36 and Reynard et al37 25-35% of men 
with LUTS strained during voiding. This is consistent with the findings in 
our study in which 44% of men with urodynamic proven BOO strained. 
The  incidence  of  straining  was  more  in  those  with  LUTS  without 
obstruction  (60%;  10/17)  on  pressure  flow  studies  but  it  was  not 
statistically  significant.  This  could  be  due  to  the  predominance  of 
hypocontractile  detrusors  in  this  group.  In  this  study  the  symptom  of 
straining was present in overall 50% of patients with 44% of those with 
BOO complaining of straining. Reynard et al had reported straining some 
or most of the time in 13% and occasionally in 44% in those with BOO.  A 
higher  prevalence  of  symptoms  is  expected  in  men  who  specifically 
present with voiding problems. Indeed, straining to void is an even more 
common symptom in men undergoing transurethral resection of prostate 
(TURP) with prevalence rate  of 35-40% being reported by Fowler  and 
Bruskewitz et al.40 
There have been few reports relating the symptom of straining to void 
with objective evidence of straining during voiding. Jensen et al noted that 
half  of  patients  who  claim  not  to  strain  did  actually  show  objective 
evidence of straining during micturition. Thirteen of 61(21%) patients in 
the study by Reynard et al showed poor agreement between the symptom 
of straining and objective evidence of its presence. In our study twenty 
seven (27/60) men with LUTS complained of straining to void. Only 12 of 
these (44%) had objective evidence of straining on pressure flow studies. 
Conversely  of  the  33  who  did  not  complain  of  straining  19  actually 
strained.  In  the  control  group  of  normal  men  without  any  LUTS 30% 
strained.  These  observations  suggest  that  a  history  of  straining  or  not 
during urination may be unreliable and there is a poor correlation between 
the  symptom  of  straining  and  its  objective  evidence.  There  was  no 
consistent pattern in our study as to the timing of straining in the voiding 
curve.  However  in  those  without  LUTS  terminal  straining  was 
predominant though not statistically significant. This could be more due to 
habit of trying to expel the last few drops of urine. All of these men when 
retrospectively  inquired  also  complained  of  straining  to  defecate 
suggesting a habitual pattern.
Few studies have looked at the relationship between abdominal straining 
and BOO. Jensen et al did not find any difference in detrusor pressures in 
men with and without straining.  In our study there  was no statistically 
significant difference in straining in those with BOO, those with LUTS 
without BOO or in normal men.  44% of those with BOO and 30% of 
normal men strained during voiding. There was a poor correlation between 
straining to void and the presence of bladder outlet obstruction.
Straining to void in patients with BOO is believed to be an initiating cause 
of inguinal hernia. Most of the surgeons believe that relief of obstruction if 
possible be carried out prior to hernia repair. However as we have shown 
that the symptom of straining is unreliable and upto 50% of those who 
claim  not  to  strain  in  fact  do  strain  to  void  on  objective  assessment. 
Further more the straining pressures observed in patients who show the 
presence of straining are, in general, low compared to those observed with 
coughing.  These  findings  in  combination  with  the  observation  that 
straining  does  not  cease  after  the  relief  of  obstruction  (Jensen  et  al) 
suggest that there is no support for the argument that evaluation to rule out 
BOO should be performed prior to inguinal hernia repair.
There  was  no difference  in  the  mean or  maximum flow rates  between 
those  who strained  and  those  who didn’t  in  all  the  3  Groups.  This  is 
consistent  with  the  study  by  Claridge  et  al  who  found  that  in  29  of 
31patients  abdominal  straining had no effect  on the  flow rate.  In  their 
study the rate in fact fell in 10 men. This was only seen in 4 men in our 
study who initially did not strain during free flow with abdominal pressure 
monitoring but later strained during urodynamics and was not significant. 
Our  current  understanding  of  the  physiology  of  the  urethra  is  that  the 
urodynamic behavior of the bladder outlet is determined by the principles 
governing  flow  through  distensible  tubes.  There  is  a  flow  controlling 
Zone,  which in  prostatic  obstruction  is  located in  the  prostatic  urethra, 
where it is under the influence of abdominal pressure. A rise in abdominal 
pressure  probably  results  in  an  increase  in  outlet  resistance  thereby 
decreasing the flow. Another way to assess the effect of straining on flow 
rate  could  be  by  asking  patients  to  whistle  during  voiding  and  then 
compare their flows. 
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Conclusions:
From this study it can be concluded that:
1)  The relationship between the symptom of straining and the objective 
evidence of its presence is poor
2)  Straining  has  a  poor  correlation  with  BOO  and  is  not  a  sensitive 
measure of BOO
3) 30% of normal men strain habitually.
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Limitations:
1) Small sample size 
2) The effect straining has on the flow rate can be best assessed by having 
consecutive flows with subjects being asked to strain at different times 
during voiding. This can be incorporated in future studies.
3) The lack of associations between some of the parameters evaluated in 
this  study  might  be  due  to  the  relatively  small  sample  size  and  the 
consequent low power of the study. Studies with larger sample sizes can 
be performed in future to more accurately assess straining.
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Annexure: Worksheet for Controls. N=40,1 Present; 2 Absent
Age H.No
free flow 
ml/sec
voided volume 
ml PVR
flow with 
pressure
straining 
+/- initial
at peak 
flow continuous intermittent
48 675133B 30 350 10 28 2
51 404437D 32 400 20 30 1 1
46 103507D 28 460 20 30 2
50 410568D 25 520 30 26 2
Srimantha 56 272972D 30 450 20 33 2
47 401340D 26 500 20 27 2
Shantana 55 413305D 28 440 25 27 1
Mohd.Alam 48 567462C 25 400 15 25 1 1
59 381381D 25 400 20 26 2
68 382343D 24 380 20 22 1 1
57 383228D 25 600 30 26 1 1
Janardhan 55 386103D 24 450 22 22 2
57 388192D 25 360 20 24 2
49 375628D 27 700 30 24 2
52 386318D 25 300 10 26 2
49 951812B 25 360 20 23 2
Sarvanan 55 893974C 26 550 20 25 1
Armugam 51 396548D 25 400 10 25 1
52 396548D 29 570 20 28 2
Amal Soni 54 389564D 33 680 20 30 2
Mohd Narul 66 395738D 26 440 20 25 2
Santosh 66 396399D 28 360 10 30 2
55 176675D 24 340 20 27 2
55 401128D 25 410 30 24 1 1
Nirul haque 48 080571D 26 300 20 24 2
49 135497D 25 380 10 20 1 1
46 771286 28 550 40 25 2
54 455759C 24 600 10 25 1 1
52 278952D 29 320 37 27 2
49 392635D 25 300 46 24 1
52 157705C 27 360 24 22 2
46 369550D 25 290 18 25 1
Jothy singh 67 558220A 25 300 16 20 2
55 397575D 30 480 28 25 2
48 405447D 26 380 22 22 2
49 407173D 28 600 38 25 2
50 225054D 26 300 22 22 2
Sampath 52 780564B 25 360 26 28 2
49 411211D 25 300 10 27 2
47 417001D 26 350 24 20 2
initial
at peak 
flow continous intermittent terminal
1
1
1
1
1
1
1
1
1
1
11
WORKSHEET CASES N=60
IPSS SCORE /
35
straining 
symptom intensity /5 flow Qmax ml/sec
voided volume 
ml PVR
Qmax with 
pressure
563756 22 1 3 7 200 60 7
365961d 24 1 2 7 250 40 6
959924c 30 2 6 180 30 7
366688
D 18 2 5 240 100 6
368870
B 22 2 8 300 30 9
092845
D 20 1 2 8 350 20 6
375429d 23 1 4 5 158 4
376159
D 18 2 9 250 30 11
371729
D 20 1 4 8 200 60 9
055778
D 14 2 9 170 150 10
388265
D 20 1 1 4 200 40 5
386486
D 23 2 8 340 20 10
393868
D 12 1 2 8 560 10 7
016226
C 20 1 2 3 200 40 4
200691
D 26 2 4 380 60 3
264925
D 21 1 1 8 260 20 6
259532d 15 2 6 180 80 8
239814
D 23 2 3 210 20 4
370191
C 22 2 8 350 10 8
271645
D 24 1 2 4 230 40 4
266784d 22 1 3 5 180 50 6
703435
A 18 1 2 5 300 30 4
217568d 16 1 3 4 210 40 3
240894
D 15 2 6 300 20 5
325725
D 17 2 9 400 20 10
388265
D 22 1 2 4 200 10 3
333196
D 12 1 3 8 350 30 9
187549
D 25 2 3 210 20 4
301835
D 20 1 4 4 170 30 5
939026
B 18 1 1 8 350 16 7
299978
D 26 2 6 300 20 6
263976
B 23 1 2 8 400 60 7
295835
D 17 2 6 320 150 8
298854
D 22 1 3 5 220 110 4
283849
D 20 1 2 4 160 120 5
234133
D 22 2 9 500 30 10
068450
D 26 1 3 7 250 10 6
straining +/- initial
at peak 
flow continous intermittent terminal Pdet Qmax Qmax
AG 
number
Straining 
+/- initial
at peak 
1 1 43 7 29 1
1 1 71 7 63 1
2 85 7 71 2
1 1 158 4 150 2
2 108 10 88 2
2 53 7 39 2
1 1 15 2 11 1
2 67 13 39 2
1 1 15 6 3 1
1 1 30 9 12 1
2 74 4 66 2
1 1 97 9 79 1
1 1 42 9 24 1
2 102 3 99 2
2 129 5 61 2
1 1 73 10 53 2
1 1 80 8 64 2
1 1 194 2 190 1
1 1 56 12 32 2
2 40 5 30 2
2 85 8 69 2
2 91 3 85 2
1 1 47 3 41 1
1 1 100 5 90 1
2 44 10 24 2
2 80 3 73 2
1 1 56 9 38 1
1 1 132 3 126 1
2 66 3 60 2
2 80 9 68 2
1 1 110 5 100 1
2 40 10 20 1
1 1 26 10 6 1
2 120 5 110 2
2 76 5 66 2
2 110 10 90 2
2 60 6 48 2
1 1 30 8 14
1 1 183 7 169 1
2 100 5 90 2
2 102 4 94 2
2 68 5 58 2
2 77 5 67 2
1 1 104 8 96 1
2 83 6 71 2
1 1 110 5 100 1
2 129 7 115 2
2 60 10 40 2
2 60 12 46 2
2 95 8 79 2
1 1 83 4 75 1
2 60 3 53 2
2 80 4 72 2
1 1 102 2 98 1
2 138 8 122 2
2 88 3 82 2
1 1 91 7 77 1
1 1 78 8 62 1 1
2 88 5 78 2
1 1 90 6 78 1 1
Straining 
+/- initial
at peak 
flow continous intermittent terminal compliance Instability
1 1
1 1
2
2
2 1
2
1 1
2
1 1 poor
1 1
2
1 1
1 1
2 poor
2
2 1
2
1 1
2
2
2
2
1 1
1 1
2
2
1 1
1 1
2
2
1 1
1 1
1 1
2
2
2
21 1
2
2
2
2
1 1
2
1 1
2
2
2 1
2
1 1
2
2
1 1
2
2
1 1
1 1
2
1 1
Worksheet for Cases N=60
1: Present
2: Absent
